GlassScriptPhysician profile
Jack O Stewart
NPI 1942278452
$19,515.70
in general payments reported to CMS, 2019-2025
56 companies · $2,670 in 2025
The $2,670 reported for 2025 was more than what 81% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,514 · 2020: $1,241 · 2021: $1,035 · 2022: $1,037 · 2023: $3,006 · 2024: $3,011 · 2025: $2,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,670 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,670.36 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $6,677.85 | 2019-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,323.83 | 2019-2025 | Ofev, Jardiance, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $1,674.97 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $1,671.94 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Merck Sharp & Dohme LLC | $597.93 | 2019-2025 | Winrevair, Dificid, Vaxneuvance |
| Genzyme Corporation | $497.91 | 2020-2025 | |
| Novo Nordisk INC | $375.90 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| United Therapeutics Corporation | $339.83 | 2022-2025 | Tyvaso, Tyvaso |
| Lilly USA, LLC | $338.67 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $332.01 | 2021-2025 | Tavneos, Tezspire, Otezla |
| Mylan Specialty L.P. | $312.76 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $309.71 | 2021-2025 | Dupixent |
| Allergan, INC. | $305.95 | 2019-2020 | |
| Pfizer INC. | $298.16 | 2019-2025 | |
| Abbvie INC. | $295.06 | 2020-2025 | Vraylar |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $205.44 | 2019-2021 | |
| Philips North America LLC | $200.52 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Takeda Pharmaceuticals U.S.A., INC. | $194.90 | 2023-2025 | Glassia |
| Janssen Pharmaceuticals, INC | $188.29 | 2019-2020 | |
| Electromed, INC. | $181.23 | 2021-2024 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $168.12 | 2019-2025 | Uptravi, Opsumit |
| Astellas Pharma US INC | $163.09 | 2019 | |
| Grifols USA, LLC | $162.95 | 2019-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $160.08 | 2025 | Ohtuvayre |
| Abiomed | $158.59 | 2022-2024 | Impella |
| Viatris Specialty LLC | $136.34 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $135.06 | 2020-2023 | Eliquis |
| Intuitive Surgical, INC. | $130.77 | 2025 | |
| Ani Pharmaceuticals, INC. | $84.56 | 2025 | Purified Cortrophin Gel |
| Vanda Pharmaceuticals INC. | $77.08 | 2020 | |
| Baxter Healthcare | $76.96 | 2023 | Hillrom - Life 2000 Ventilation System |
| Vifor Pharma, INC. | $72.61 | 2024 | Zemaira, Veltassa |
| Novartis Pharmaceuticals Corporation | $66.95 | 2019-2023 | |
| Aimmune Therapeutics, INC. | $48.09 | 2024-2025 | Vowst, Zenpep |
| Paratek Pharmaceuticals, INC. | $45.44 | 2024-2025 | Nuzyra |
| Idorsia Pharmaceuticals US INC | $42.14 | 2023 | Quviviq |
| Axsome Therapeutics, INC. | $40.83 | 2023 | Sunosi |
| Pulmonx Corporation | $40.03 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Advanced Respiratory, INC | $31.89 | 2021 | |
| Mayne Pharma Commercial LLC | $31.35 | 2020 | |
| Edwards Lifesciences Corporation | $30.66 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Teleflex LLC | $30.62 | 2025 | Urolift |
| Inspire Medical Systems, INC. | $28.20 | 2024 | Inspire |
| Medtronic, INC. | $23.65 | 2022 | |
| Azurity Pharmaceuticals, INC. | $22.39 | 2025 | Alvesco |
| Nabriva Therapeutics, Plc | $22.25 | 2022 | |
| Amarin Pharma, INC. | $20.81 | 2020 | |
| Hologic Sales and Service, LLC | $20.64 | 2022 | |
| Phadia US INC. | $19.67 | 2020 | |
| Zoll Respicardia, INC. | $16.96 | 2025 | Remede System |
| Exact Sciences Corporation | $15.48 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $15.18 | 2024 | Gemtesa |
| Vertiflex, INC. | $14.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.93 | 2019 | |
| Sanofi Pasteur INC. | $13.09 | 2019 | |
| Tactile Systems Technology INC | $12.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.